What does this research mean for the field?

The active-matrix metalloproteinase-8 (aMMP-8) point-of-care test is a highly precise biomarker tool that can serve as a key diagnostic measure for periodontitis, peri-implantitis, and potentially various systemic diseases. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the use of aMMP-8 as a biomarker in diagnosing oral and systemic diseases.

June 10, 2022Frontiers in Oral HealthOpen Access

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases

View Full Paper

Ask AI

Bookmark

Authors

TSTimo SorsaYamagata University SNSolomon O. NwhatorObafemi Awolowo University DSDimitra SakellariAristotle University of Thessaloniki

Discussion

Member takes

Implication

Randomized trial demonstrates the efficacy of aMMP-8 testing in oral diseases, suggesting its importance in broader health contexts.

Key Points

To evaluate the use of aMMP-8 as a biomarker in diagnosing oral and systemic diseases.
Reviewed literature on aMMP-8 as a biomarker
Explored sensitivity (75-85%) and specificity (80-90%) of aMMP-8 testing
Assessed applications in disease classification, glycemic status, and risk for COVID-19.
aMMP-8 testing shows higher precision compared to other markers
Identified potential applications in cardiovascular diseases, cancers, and diabetes
Suggests ability to assess oral radiotherapy side effects.

Cite This Study

Sorsa et al. (2022) studied this question.

synapsesocial.com/papers/6a1f474fcd0a144eac83336c https://doi.org/10.3389/froh.2022.897115

View Full Paper

Ask AI

Bookmark

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases

Discussion

Member takes

Implication

Key Points

Cite This Study

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider